Loading insider details...
Beta
Latest Form 4 (Sep 10, 2026): In-the-Money Exercise of 2,293 AQST shares, $2.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 10, 2026 | Aquestive Therapeutics, Inc. (AQST) | In-the-Money Exercise | 2,293 | $2.2K |
| May 7, 2026 | Aquestive Therapeutics, Inc. (AQST) | Tax Withholding | 56,778 | $237.3K |
| Apr 13, 2026 | Aquestive Therapeutics, Inc. (AQST) | Grant/Award | 60,000 | n/a |
| Mar 11, 2026 | Aquestive Therapeutics, Inc. (AQST) | Grant/Award | 80,000 | n/a |
| Dec 5, 2025 | Aquestive Therapeutics, Inc. (AQST) | Grant/Award | 20,000 | n/a |
| Oct 17, 2025 | Aquestive Therapeutics, Inc. (AQST) | Sale | 10,000 | $70.0K |
| Sep 29, 2025 | Aquestive Therapeutics, Inc. (AQST) | Sale | 10,000 | $63.0K |
| Sep 8, 2025 | Aquestive Therapeutics, Inc. (AQST) | Sale | 15,000 | $79.5K |
| Mar 11, 2025 | Aquestive Therapeutics, Inc. (AQST) | Grant/Award | 80,000 | n/a |
| Mar 12, 2024 | Aquestive Therapeutics, Inc. (AQST) | Tax Withholding | 8,370 | $40.8K |